BTMD News and Press, Biote Corp. From 05/06/24

2024-05-06 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-29 16:11:29 ET More on BIOTE Biote announces agreement to resolve litigation with founder Gary Donovitz Seeking Alpha’s Quant Rating on BIOTE Historical earnings data for BIOTE Financial information for BIOTE Read the full article on ...

Company to repurchase all of Founder’s 18.4 million shares at $4.17 per share biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

2024-04-26 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on...

2024-04-07 07:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-13 10:00:21 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...

2024-03-12 19:45:21 ET biote Corp. (FSNUF) Q4 2023 Earnings Conference Call March 12, 2024 05:00 PM ET Company Participants Simon Serowiecki - Investor Relations Terry Weber - Chief Executive Officer Bob Peterson - Chief Financial Officer Marc Beer - Executiv...

2024-03-12 16:17:40 ET More on BIOTE Biote announces agreement to resolve litigation with founder Gary Donovitz Biote to buy Asteria Health for $8.5M Seeking Alpha’s Quant Rating on BIOTE Historical earnings data for BIOTE Financial information...

Grew practitioner network to over 7,100 from 6,400 in 2022 Launched BioteRx, our new hormone and therapeutic wellness offerings Enhancing shareholder value with agreement to repurchase 18.4M founders’ shares in addition to a separate $20M share repurchase program Re...